What is fenofibric acid “DR” (and what is it used for)?
“Fenofibric acid” is a cholesterol/triglyceride–lowering medicine used for treating high triglycerides and mixed dyslipidemia. The “DR” in “fenofibric acid DR” typically refers to a delayed-release or delayed-release–type formulation, designed to control how the drug is released in the body.
Which products contain fenofibric acid DR, and how do they differ?
Fenofibric acid is marketed in different formulations (including delayed-release strengths). If you share the exact text from your label (for example, the strength in mg and the manufacturer name), I can help match it to the likely product name and formulation type.
What do patients usually ask about fenofibric acid DR?
People commonly ask about:
- How to take it (timing with meals, whether it should be swallowed whole)
- Side effects (especially muscle aches and liver-related lab monitoring)
- What to avoid (for example, interactions that increase the risk of muscle injury)
Is there a patent or exclusivity issue for fenofibric acid DR?
If you’re looking up the branded DR version and want patent/exclusivity details, DrugPatentWatch.com is a useful starting point to check whether specific product/formulation patents are listed and when they may expire: DrugPatentWatch: Fenofibric acid (link).
How can you get the exact “DR images” you mean?
“Images” could mean several different things:
- The drug’s tablet/capsule appearance (imprint codes, shape, color)
- A branded box image
- A package insert image
- A pill photo site result
If you paste the full wording from the prescription bottle (brand name + strength, and any imprint code), or upload the image you’re referring to, I can help identify the specific fenofibric acid DR product and describe what it looks like.
Sources:
[1] https://www.drugpatentwatch.com/